BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 31597252)

  • 21. SpCas9- and LbCas12a-Mediated DNA Editing Produce Different Gene Knockout Outcomes in Zebrafish Embryos.
    Meshalkina DA; Glushchenko AS; Kysil EV; Mizgirev IV; Frolov A
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32635161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex.
    Bai Y; Wang W; Li S; Zhan J; Li H; Zhao M; Zhou XA; Li S; Li X; Huo Y; Shen Q; Zhou M; Zhang H; Luo J; Sung P; Zhu WG; Xu X; Wang J
    Mol Cell; 2019 Sep; 75(6):1299-1314.e6. PubMed ID: 31353207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison and optimization of different CRISPR/Cas9 donor-adapting systems for gene editing.
    Bao-Xia M; Sen Y; Ming L; Yu-Ren W; Li-Ye C; Yi-Fan H; Jian-Gang W; Yang G; Kun X
    Yi Chuan; 2024 Jun; 46(6):466-477. PubMed ID: 38886150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing CRISPR/Cas9-mediated homology-directed DNA repair by histone deacetylase inhibitors.
    Li G; Zhang X; Wang H; Liu D; Li Z; Wu Z; Yang H
    Int J Biochem Cell Biol; 2020 Aug; 125():105790. PubMed ID: 32534122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9
    Li Q; Seys FM; Minton NP; Yang J; Jiang Y; Jiang W; Yang S
    Biotechnol Bioeng; 2019 Jun; 116(6):1475-1483. PubMed ID: 30739328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure.
    Yan Q; Xu K; Xing J; Zhang T; Wang X; Wei Z; Ren C; Liu Z; Shao S; Zhang Z
    Sci Rep; 2016 Dec; 6():38970. PubMed ID: 27941919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
    Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
    PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination.
    Martin RM; Ikeda K; Cromer MK; Uchida N; Nishimura T; Romano R; Tong AJ; Lemgart VT; Camarena J; Pavel-Dinu M; Sindhu C; Wiebking V; Vaidyanathan S; Dever DP; Bak RO; Laustsen A; Lesch BJ; Jakobsen MR; Sebastiano V; Nakauchi H; Porteus MH
    Cell Stem Cell; 2019 May; 24(5):821-828.e5. PubMed ID: 31051134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotype-specific restriction of wild-type adenoviruses by the cellular Mre11-Rad50-Nbs1 complex.
    Pancholi NJ; Weitzman MD
    Virology; 2018 May; 518():221-231. PubMed ID: 29547809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
    Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
    PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protocol of tagging endogenous proteins with fluorescent tags using CRISPR-Cas9 genome editing.
    Wu ZS; Gao Y; Du YT; Dang S; He KM
    Yi Chuan; 2023 Feb; 45(2):165-175. PubMed ID: 36927663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A novel CRISPR/Cas9-hLacI donor adapting system for dsDNA-templated gene editing].
    Ma B; Cui J; Qian H; Zhang X; Yang S; Zhang Q; Han Y; Zhang Z; Wang J; Xu K
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4204-4218. PubMed ID: 37877400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA-Guided Recombinase-Cas9 Fusion Targets Genomic DNA Deletion and Integration.
    Standage-Beier K; Brookhouser N; Balachandran P; Zhang Q; Brafman DA; Wang X
    CRISPR J; 2019 Aug; 2(4):209-222. PubMed ID: 31436506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
    Lin C; Li H; Hao M; Xiong D; Luo Y; Huang C; Yuan Q; Zhang J; Xia N
    Sci Rep; 2016 Oct; 6():34531. PubMed ID: 27713537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.
    Schubert MS; Thommandru B; Woodley J; Turk R; Yan S; Kurgan G; McNeill MS; Rettig GR
    Sci Rep; 2021 Sep; 11(1):19482. PubMed ID: 34593942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of SpCas9 to E. coli Rec A protein enhances CRISPR-Cas9 mediated gene knockout in mammalian cells.
    Lin L; Petersen TS; Jensen KT; Bolund L; Kühn R; Luo Y
    J Biotechnol; 2017 Apr; 247():42-49. PubMed ID: 28259533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MCM8-9 complex promotes resection of double-strand break ends by MRE11-RAD50-NBS1 complex.
    Lee KY; Im JS; Shibata E; Park J; Handa N; Kowalczykowski SC; Dutta A
    Nat Commun; 2015 Jul; 6():7744. PubMed ID: 26215093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells.
    Na J; Newman JA; Then CK; Syed J; Vendrell I; Torrecilla I; Ellermann S; Ramadan K; Fischer R; Kiltie AE
    Cell Death Dis; 2021 Feb; 12(2):165. PubMed ID: 33558481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.